Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm classically described as triphasic disease: chronic, accelerated, and blast crisis. There are many unmet needs and unanswered questions about CML. Intermittent fasting in patients with CML on tyrosine kinase inhibitors is among these un...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Dubai, Husam N., Yassin, Mohammed A., Abdulla, Mohammed A., Aldapt, Mahmood S., Ghassoub, Rola S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383202/
https://www.ncbi.nlm.nih.gov/pubmed/32774253
http://dx.doi.org/10.1159/000507508
_version_ 1783563402287775744
author Al-Dubai, Husam N.
Yassin, Mohammed A.
Abdulla, Mohammed A.
Aldapt, Mahmood S.
Ghassoub, Rola S.
author_facet Al-Dubai, Husam N.
Yassin, Mohammed A.
Abdulla, Mohammed A.
Aldapt, Mahmood S.
Ghassoub, Rola S.
author_sort Al-Dubai, Husam N.
collection PubMed
description Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm classically described as triphasic disease: chronic, accelerated, and blast crisis. There are many unmet needs and unanswered questions about CML. Intermittent fasting in patients with CML on tyrosine kinase inhibitors is among these unmet needs. Here we report the effect of intermittent fasting on response to nilotinib as upfront in a 49-year-old female Muslim who fasted during Ramadan and took her medication once instead of twice daily and remained in major molecular response.
format Online
Article
Text
id pubmed-7383202
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-73832022020-08-07 Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront Al-Dubai, Husam N. Yassin, Mohammed A. Abdulla, Mohammed A. Aldapt, Mahmood S. Ghassoub, Rola S. Case Rep Oncol Case Report Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm classically described as triphasic disease: chronic, accelerated, and blast crisis. There are many unmet needs and unanswered questions about CML. Intermittent fasting in patients with CML on tyrosine kinase inhibitors is among these unmet needs. Here we report the effect of intermittent fasting on response to nilotinib as upfront in a 49-year-old female Muslim who fasted during Ramadan and took her medication once instead of twice daily and remained in major molecular response. S. Karger AG 2020-06-15 /pmc/articles/PMC7383202/ /pubmed/32774253 http://dx.doi.org/10.1159/000507508 Text en Copyright © 2020 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Al-Dubai, Husam N.
Yassin, Mohammed A.
Abdulla, Mohammed A.
Aldapt, Mahmood S.
Ghassoub, Rola S.
Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
title Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
title_full Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
title_fullStr Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
title_full_unstemmed Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
title_short Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
title_sort ramadan fasting in a patient with chronic myeloid leukemia receiving nilotinib as upfront
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383202/
https://www.ncbi.nlm.nih.gov/pubmed/32774253
http://dx.doi.org/10.1159/000507508
work_keys_str_mv AT aldubaihusamn ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront
AT yassinmohammeda ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront
AT abdullamohammeda ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront
AT aldaptmahmoods ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront
AT ghassoubrolas ramadanfastinginapatientwithchronicmyeloidleukemiareceivingnilotinibasupfront

Ejemplares similares